IP Library Patent Application 13446820
Patent Application
App. No. 13/446,820

SYSTEMS AND METHODS FOR DE-RISKING PATIENT TREATMENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/446,820
Abstract

The present disclosure describes systems and methods for de-risking patient treatment by identifying medications or combinations of medications to be contraindicated for a specific indication. An analyzer executed by a processor of a computing device from a user may receive an identification of an indication (e.g. the subject of a clinical trial, or the diagnosis of a patient visiting a physician's office). The analyzer may retrieve, from an adverse event database, medication and co-medication information of patients that experienced a side effect corresponding to the indication. The analyzer may sort the retrieved medication and co-medication information to generate an ordered list of medications consumed by patients that experienced the side effect, and identify a first medication of the ordered list. A display module executed by the computing device may display, to the user, the first medication of the ordered list for contraindication from the clinical trial.

Claims (35)

1 . A method for identifying a medication for contraindication from an indication, comprising:

receiving, by an analyzer executed by a processor of a computing device from a user, an identification of an indication of a first patient;

retrieving, by the analyzer from an adverse event database, medication and co-medication information of patients that experienced a side effect corresponding to the indication;

sorting the retrieved medication and co-medication information, by the analyzer, to generate an ordered list of medications consumed by patients that experienced the side effect;

identifying, by the analyzer, a first medication of the ordered list; and

displaying, by a display module executed by the computing device to the user, the first medication of the ordered list for contraindication for the first patient.

2 . The method of claim 1 , further comprising determining, by the analyzer, that an organ is associated with the indication; and wherein retrieving medication and co-medication information of patients that experienced the side effect further comprises extracting a subset from the retrieved information of medications and co-medications identified as affecting the organ.

3 . The method of claim 1 , further comprising identifying, by the analyzer, a molecular interaction associated with the side effect; and identifying the first medication, responsive to the first medication identified in a medication information database as affecting the identified molecular interaction.

4 . The method of claim 1 , wherein identifying a first medication comprises determining a proportional reporting ratio of the first medication to all medications in the ordered list, and identifying the first medication, responsive to the proportional reporting ratio being above a predetermined threshold.

5 . The method of claim 1 , wherein sorting the retrieved medication and co-medication information comprises scoring each medication in the list responsive to its frequency of appearance in the retrieved medication and co-medication information, and sorting the list by score.

6 . The method of claim 1 , further comprising identifying, by the analyzer, a combination of a second medication and third medication appearing together in the retrieved medication and co-medication information at a statistical rate above a predetermined threshold; and displaying, by the display module, the combination of the second medication and third medication for contraindication from the clinical trial.

7 . A system for identifying a medication for contraindication from an indication, comprising:

a computing device comprising a processor executing

an analyzer configured for

receiving, from a user, an identification of an indication of a first patient,

retrieving, from an adverse event database, medication and co-medication information of patients that experienced a side effect corresponding to the indication,

sorting the retrieved medication and co-medication information to generate an ordered list of medications consumed by patients that experienced the side effect, and

identifying, by the analyzer, a first medication of the ordered list; and

a display module configured for displaying the first medication of the ordered list for contraindication from the first patient.

8 . The system of claim 7 , wherein the analyzer is further configured for determining that an organ is associated with the indication; and wherein retrieving medication and co-medication information of patients that experienced the side effect further comprises extracting a subset from the retrieved information of medications and co-medications identified as affecting the organ.

9 . The system of claim 7 , wherein the analyzer is further configured for identifying a molecular interaction associated with the side effect; and identifying the first medication, responsive to the first medication identified in a medication information database as affecting the identified molecular interaction.

10 . The system of claim 7 , wherein the analyzer is further configured for determining a proportional reporting ratio of the first medication to all medications in the ordered list, and identifying the first medication, responsive to the proportional reporting ratio being above a predetermined threshold.

11 . The system of claim 7 , wherein the analyzer is further configured for scoring each medication in the list responsive to its frequency of appearance in the retrieved medication and co-medication information, and sorting the list by score.

12 . The system of claim 7 , wherein the analyzer is further configured for identifying a combination of a second medication and third medication appearing together in the retrieved medication and co-medication information at a statistical rate above a predetermined threshold; and the display module is further configured for displaying the combination of the second medication and third medication for contraindication from the clinical trial.

13 . A computer readable storage device comprising computer-readable instructions for identifying a medication for contraindication from an indication, comprising:

instructions for receiving, by an analyzer executed by a processor of a computing device from a user, an identification of an indication of a first patient;

instructions for retrieving, by the analyzer from an adverse event database, medication and co-medication information of patients that experienced a side effect corresponding to the indication;

instructions for sorting the retrieved medication and co-medication information, by the analyzer, to generate an ordered list of medications consumed by patients that experienced the side effect;

instructions for identifying, by the analyzer, a first medication of the ordered list; and

instructions for displaying, by a display module executed by the computing device to the user, the first medication of the ordered list for contraindication from the first patient.

14 . The computer readable storage device of claim 13 , further comprising instructions for determining, by the analyzer, that an organ is associated with the indication; and wherein retrieving medication and co-medication information of patients that experienced the side effect further comprises extracting a subset from the retrieved information of medications and co-medications identified as affecting the organ.

15 . The computer readable storage device of claim 13 , further comprising instructions for identifying, by the analyzer, a molecular interaction associated with the side effect; and identifying the first medication, responsive to the first medication identified in a medication information database as affecting the identified molecular interaction.

16 . The computer readable storage device of claim 13 , further comprising instructions for determining a proportional reporting ratio of the first medication to all medications in the ordered list, and identifying the first medication, responsive to the proportional reporting ratio being above a predetermined threshold.

17 . The computer readable storage device of claim 13 , further comprising instructions for scoring each medication in the list responsive to its frequency of appearance in the retrieved medication and co-medication information, and sorting the list by score.

18 . The computer readable storage device of claim 13 , further comprising instructions for identifying, by the analyzer, a combination of a second medication and third medication appearing together in the retrieved medication and co-medication information at a statistical rate above a predetermined threshold; and displaying, by the display module, the combination of the second medication and third medication for contraindication from the clinical trial.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2014
From: MOLECULAR HEALTH AG
To: MOLECULAR HEALTH GMBH
Reel/Frame 034628/0656 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2012
From: JACKSON, DAVID; SOLDATOS, THEODOROS; TAGLANG, GUILLAUME; ZIEN, ALEXANDER; BROCK, STEPHAN
To: MOLECULAR HEALTH AG
Reel/Frame 028443/0807 →